News German drug companies are criticised for not focusing on useful therapeutic areas BMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h4938 (Published 15 September 2015) Cite this as: BMJ 2015;351:h4938 Article Related content Metrics Responses Peer review Related articles News Only 3 in 20 new drugs approved in Germany in 2011 were an improvement, report says Published: 08 April 2014; BMJ 348 doi:10.1136/bmj.g2657 News German drug industry says pricing law is restricting access to some drugs Published: 17 November 2015; BMJ 351 doi:10.1136/bmj.h6205 Cited by... German drug industry says pricing law is restricting access to some drugsFulltext PDF
